Shinya Kaname
Overview
Explore the profile of Shinya Kaname including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
655
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaname S, Ong M, Mathias J, Gatta F, Law L, Wang Y
Transfus Apher Sci
. 2024 Dec;
64(1):104048.
PMID: 39729821
Plasma exchange (PE) outcomes in patients with trigger-associated thrombotic microangiopathy (TMA) have not been comprehensively reviewed. Embase and MEDLINE® were searched on 03/14/2022 for English language articles published after 2007,...
2.
Katsumata Y, Sada K, Kameda T, Dobashi H, Kaname S, Tsuboi N, et al.
Immunol Med
. 2024 Oct;
48(1):47-57.
PMID: 39391948
We compared different antineutrophil cytoplasmic antibody (ANCA) detection methods using a predominantly myeloperoxidase (MPO)-ANCA-associated vasculitis cohort. Stored sera from 147 patients with untreated ANCA-associated vasculitis (AAV), including microscopic polyangiitis and...
3.
Nagase M, Ando H, Beppu Y, Kurihara H, Oki S, Kubo F, et al.
J Am Soc Nephrol
. 2024 Jun;
35(10):1366-1380.
PMID: 38844335
No abstract available.
4.
Maruyama S, Ikeda Y, Kaname S, Kato N, Matsumoto M, Ishikawa Y, et al.
J Nephrol
. 2024 May;
37(8):2181-2190.
PMID: 38809358
Background: Eculizumab has been approved for atypical haemolytic-uraemic syndrome (aHUS) in Japan since 2013. Post-marketing surveillance enrolled patients with aHUS who received ≥ 1 dose of eculizumab to assess eculizumab...
5.
Kawazoe M, Nanki T, Saeki K, Ishikawa H, Nakamura Y, Kawashima S, et al.
Mod Rheumatol
. 2024 Feb;
34(6):1284-1287.
PMID: 38343272
No abstract available.
6.
Abe M, Hatta T, Imamura Y, Sakurada T, Kaname S
Kidney Res Clin Pract
. 2023 Oct;
PMID: 37885176
Background: Multidisciplinary team-based integrated care (MDC) has been recommended for patients with chronic kidney disease (CKD). However, team-based specific structured care systems are not yet established. Therefore, we investigated the...
7.
Sada K, Nagasaka K, Kaname S, Nango E, Kishibe K, Dobashi H, et al.
Mod Rheumatol
. 2023 Aug;
34(3):559-567.
PMID: 37599461
Objective: To revise the 2017 clinical practice guidelines (CPG) for the management of microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) to reflect advancements in the field. Methods: Similar to...
8.
Abe M, Hatta T, Imamura Y, Sakurada T, Kaname S
Front Endocrinol (Lausanne)
. 2023 Jul;
14:1180477.
PMID: 37409235
Background: Multidisciplinary care is necessary to prevent worsening renal function and all-cause mortality in patients with chronic kidney disease (CKD) but has mostly been investigated in the outpatient setting. In...
9.
Sada K, Nagasaka K, Kaname S, Higuchi T, Furuta S, Nanki T, et al.
Mod Rheumatol
. 2023 Jun;
34(3):551-558.
PMID: 37279574
Objective: This study aimed to evaluate the Ministry of Health, Labour and Welfare (MHLW) diagnostic criteria for antineutrophil cytoplasmic antibody-associated vasculitis compared to the new American College of Rheumatology/European Alliance...
10.
Abe M, Hatta T, Imamura Y, Sakurada T, Kaname S
Clin Exp Nephrol
. 2023 Mar;
27(6):528-541.
PMID: 37002509
Background: Multidisciplinary care is well established in clinical practice, but its effectiveness in patients with chronic kidney disease (CKD) remains unclear. The aim of this study was to determine whether...